Nurix Therapeutics Inc [NRIX]
Pivot-данные
Статистика pivot
| Метрика | Среднее | Медиана | Ст. откл. |
|---|---|---|---|
| Рост % | 32.51% | 29.51% | 25.43% |
| Падение % | -17.65% | -15.47% | 11.35% |
| Длительность | 20.3d | 16d | 15.1d |
| Всего найдено pivot | 46 |
| Фазы роста/падения | 45 (22 Рост / 23 Падение) |
| Последний pivot | Top @ $17.76 на 2026-05-29 |
| Изменение с последнего pivot | $-0.72 (-4.05%) |
Прогноз следующего pivot Последняя: $17.04
| Ожидаемый следующий тип | Bottom |
| Прогноз цены (средн.) | $14.63 |
| Прогноз цены (медиана) | $15.01 |
| Прогноз диапазона цены (~68%) | $12.61 - $16.64 |
| Изменение к средней цели | $-2.41 (-14.17%) |
| Прогноз даты (средн.) | 2026-06-18 |
| Прогноз диапазона дат (~68%) | 2026-06-03 - 2026-07-03 |
| Основа | Based on 23 historical losses (Avg: -17.65%, Median: -15.47%, StdDev of Abs: 11.35%) and duration (Avg: 20.3 days, StdDev: 15.1 days) |
| Примечание | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Modest rise for Nurix Therapeutics Inc.
Nurix Therapeutics Inc (NRIX) stock price showed improvement on Monday after the stock rose $0.0900 (0.53%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 3.07% rise. Yesterday's trading volume was 2.68M shares, worth about $45.70M. This represents 118 926 shares more than the day before. Volume was below the 10-day average of 4.33M shares.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (23.3%), medium- (23.3%), and long-term (23.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is approaching the closest resistance level at $17.50. approximately $0.460 (2.70%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -
Nurix Therapeutics Inc Evaluation
- Короткий оценка: 1.22
- Средний оценка: 3.09
- Длинный оценка: 2.92